content: SECURITIES AND EXCHANGE COMMISSION
                      Washington D.C. 20549
  
                            FORM 8-K
  
  
        Current Report Pursuant to Section 13 or 15(d) of
                   The Securities Act of 1934
  
  
  Date of Report (Date of earliest event reported)  August 25, 1998
  
  
                            EP MedSystems, Inc.
      ------------------------------------------------------
      (Exact name of registrant as specified in its charter)
                                
                                
                   Commission file number   0-28260
                                            -------
  
            New Jersey                               22-3212190
   ----------------------------------------------   -----------
   (State or other jurisdiction of incorporation)   (IRS Employer
                                                    Identification No.)
  
  
  100 Stierli Court, Mount Arlington, New Jersey        07865
  ----------------------------------------------        -------
    (Address of principal executive offices)            (Zip Code)
  
  
  Registrant's telephone number:     (973) 398-2800
                                     --------------
  
  <PAGE>
  
  ITEM 4.  CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
  
  Arthur  Andersen  LLP  has  been  the  Company's  certifying
  accountant since the inception of the Company in  1993.   On
  August  25,  1998 the Company notified Arthur Andersen  that
  the  audit  committee recommended and the board of directors
  approved a change in the Company's certifying accountants to
  PricewaterhouseCoopers LLP for the audit  of  the  Company's
  financial  statements for the year ended December 31,  1998.
  PricewaterhouseCoopers  was  engaged  by  the   Company   as
  certifying accountant effective August 25, 1998.
  
  Arthur   Andersen's   report  on  the  Company's   financial
  statements for each of the past two years did not contain an
  adverse  opinion  or a disclaimer of opinion,  and  was  not
  qualified  nor modified as to uncertainty, audit  scope,  or
  accounting principles.
  
  During  the Company's two most recent fiscal years  and  any
  subsequent   interim   period  preceding   the   change   in
  accountants,  there were no disagreements  with  the  former
  accountant  on  any  matter  of  accounting  principles   or
  practices, financial statement disclosure, or auditing scope
  or  procedure, which disagreements, if not resolved  to  the
  satisfaction of the former accountant, would have caused  it
  to   make  a  reference  to  the  subject  matter   of   the
  disagreements in connection with its report.
  
  During  the Company's two most recent fiscal years  and  the
  subsequent  interim  period  preceding  the  change  in  the
  Company's  certifying accountant, none of the events  listed
  in  paragraphs  (a)(1)(v)(A) through  (D)  of  Item  304  of
  Regulation S-K occurred.
  
  During  the Company's two most recent fiscal years  and  the
  subsequent  interim period prior to engaging  the  Company's
  new  certifying  accountant, the  Company's  new  certifying
  accountant  was not consulted regarding any of  the  matters
  set forth in paragraphs (a)(2) of Item 304 of Regulation  S-K.
  
  The Company has asked Arthur Andersen LLP to furnish it with
  a   letter,   addressed  to  the  Securities  and   Exchange
  Commission,  stating  whether or  not  Arthur  Andersen  LLP
  agrees with the above statements.  A copy of such letter  is
  filed as Exhibit 16 of this Report.
  
  
  ITEM   7.   FINANCIAL   STATEMENTS,  PRO   FORMA   FINANCIAL
  INFORMATION AND EXHIBITS
  
  Exhibits
  
  Exhibit 16     Letter from Arthur Andersen LLP to the
                 Securities and  Exchange Commission dated
                 August 28, 1998.
  
  
  
  
                            SIGNATURE
  Pursuant to the requirements of the Securities Exchange  Act
  of  1934, the registrant has duly caused this report  to  be
  signed  on  its  behalf  by  the undersigned  hereunto  duly
  authorized.
  
                                           EP MEDSYSTEMS, INC.
  
  Dated:  August 28, 1998            By  /s/ James J. Caruso
                                         --------------------
                                         James J. Caruso
                                         Vice   President  and  Chief
                                         Financial Officer
  
  EXHIBIT INDEX
  
  Exhibit Number Description
  
  Exhibit 16     Letter from Arthur Andersen LLP to the
                 Securities and  Exchange Commission dated
                 August 28, 1998.
  
  
  <PAGE>
  
  
                                                    EXHIBIT 16
  
                   ARTHUR ANDERSEN LETTERHEAD
  
  
  August 28, 1998
  
  Office of the Chief Accountant
  Securities and Exchange Commission
  450 Fifth Street NW
  Washington DC 20549
  
  
  Dear Sir:
  
  We  have  read Item 4 included in the Form 8-K dated  August
  28,  1998  of  EP  MedSystems, Inc. to  be  filed  with  the
  Securities and Exchange Commission and are in agreement with
  the statements contained therein.
  
  Very truly yours,
  
  /s/  Arthur Andersen LLP
  ------------------------
  
  cc:  Mr. James J. Caruso, EP MedSystems, Inc.
metadata_documents: [{"type": "8-K", "sequence": "1", "secsgml_size_bytes": 5039}]
metadata_filer: {"company-data": {"conformed-name": "EP MEDSYSTEMS INC", "cik": "0001012394", "assigned-sic": "3841", "irs-number": "223212190", "state-of-incorporation": "NJ", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-28260", "film-number": "98700937"}, "business-address": {"street1": "100 STIERLI COURT", "street2": "SUITE 107", "city": "MOUNT ARLINGTON", "state": "NJ", "zip": "07856", "phone": "973-398-2800"}, "mail-address": {"street1": "58 ROUTE 46 WEST", "city": "BUDD LAKE", "state": "NJ", "zip": "07828"}}
text: SECURITIES AND EXCHANGE COMMISSION
                      Washington D.C. 20549
  
                            FORM 8-K
  
        Current Report Pursuant to Section 13 or 15(d) of
                   The Securities Act of 1934
  
  Date of Report (Date of earliest event reported)  August 25, 1998
  
                            EP MedSystems, Inc.
      ------------------------------------------------------
      (Exact name of registrant as specified in its charter)
                                
                                
                   Commission file number   0-28260
                                            -------
  
            New Jersey                               22-3212190
   ----------------------------------------------   -----------
   (State or other jurisdiction of incorporation)   (IRS Employer
                                                    Identification No.)
  
  100 Stierli Court, Mount Arlington, New Jersey        07865
  ----------------------------------------------        -------
    (Address of principal executive offices)            (Zip Code)
  
  Registrant's telephone number:     (973) 398-2800
                                     --------------
  ITEM 4.  CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
  
  Arthur  Andersen  LLP  has  been  the  Company's  certifying
  accountant since the inception of the Company in  1993.   On
  August  25,  1998 the Company notified Arthur Andersen  that
  the  audit  committee recommended and the board of directors
  approved a change in the Company's certifying accountants to
  PricewaterhouseCoopers LLP for the audit  of  the  Company's
  financial  statements for the year ended December 31,  1998.
  PricewaterhouseCoopers  was  engaged  by  the   Company   as
  certifying accountant effective August 25, 1998.
  
  Arthur   Andersen's   report  on  the  Company's   financial
  statements for each of the past two years did not contain an
  adverse  opinion  or a disclaimer of opinion,  and  was  not
  qualified  nor modified as to uncertainty, audit  scope,  or
  accounting principles.
  
  During  the Company's two most recent fiscal years  and  any
  subsequent   interim   period  preceding   the   change   in
  accountants,  there were no disagreements  with  the  former
  accountant  on  any  matter  of  accounting  principles   or
  practices, financial statement disclosure, or auditing scope
  or  procedure, which disagreements, if not resolved  to  the
  satisfaction of the former accountant, would have caused  it
  to   make  a  reference  to  the  subject  matter   of   the
  disagreements in connection with its report.
  
  During  the Company's two most recent fiscal years  and  the
  subsequent  interim  period  preceding  the  change  in  the
  Company's  certifying accountant, none of the events  listed
  in  paragraphs  (a)(1)(v)(A) through  (D)  of  Item  304  of
  Regulation S-K occurred.
  
  During  the Company's two most recent fiscal years  and  the
  subsequent  interim period prior to engaging  the  Company's
  new  certifying  accountant, the  Company's  new  certifying
  accountant  was not consulted regarding any of  the  matters
  set forth in paragraphs (a)(2) of Item 304 of Regulation  S-K.
  
  The Company has asked Arthur Andersen LLP to furnish it with
  a   letter,   addressed  to  the  Securities  and   Exchange
  Commission,  stating  whether or  not  Arthur  Andersen  LLP
  agrees with the above statements.  A copy of such letter  is
  filed as Exhibit 16 of this Report.
  
  ITEM   7.   FINANCIAL   STATEMENTS,  PRO   FORMA   FINANCIAL
  INFORMATION AND EXHIBITS
  
  Exhibits
  
  Exhibit 16     Letter from Arthur Andersen LLP to the
                 Securities and  Exchange Commission dated
                 August 28, 1998.
  
                            SIGNATURE
  Pursuant to the requirements of the Securities Exchange  Act
  of  1934, the registrant has duly caused this report  to  be
  signed  on  its  behalf  by  the undersigned  hereunto  duly
  authorized.
  
                                           EP MEDSYSTEMS, INC.
  
  Dated:  August 28, 1998            By  /s/ James J. Caruso
                                         --------------------
                                         James J. Caruso
                                         Vice   President  and  Chief
                                         Financial Officer
  
  EXHIBIT INDEX
  
  Exhibit Number Description
  
  Exhibit 16     Letter from Arthur Andersen LLP to the
                 Securities and  Exchange Commission dated
                 August 28, 1998.
  EXHIBIT 16
  
                   ARTHUR ANDERSEN LETTERHEAD
  
  August 28, 1998
  
  Office of the Chief Accountant
  Securities and Exchange Commission
  450 Fifth Street NW
  Washington DC 20549
  
  Dear Sir:
  
  We  have  read Item 4 included in the Form 8-K dated  August
  28,  1998  of  EP  MedSystems, Inc. to  be  filed  with  the
  Securities and Exchange Commission and are in agreement with
  the statements contained therein.
  
  Very truly yours,
  
  /s/  Arthur Andersen LLP
  ------------------------
  
  cc:  Mr. James J. Caruso, EP MedSystems, Inc.